Preferred Label : Continued Access Study;
NCIt related terms : Continued Access; post-trial access;
Alternative definition : CDISC: Expanded access to an investigational medical product (drug, biologic, or medical
device) for treatment use in subjects after the controlled clinical trial has been
completed and while the marketing application is being prepared by the sponsor or
reviewed by the regulator.; MRCT-Ctr: When participants can still receive a study treatment after their participation
has ended. (https://mrctcenter.org/glossaryterm/post-trial-access/);
NCI Metathesaurus CUI : CL1792347;
Origin ID : C187706;
UMLS CUI : C5707303;
Semantic type(s)
- concept_is_in_subset
